Moleculin Biotech News - MBRX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.5755 0.00 0.00 0.00 0.5755 04:00:01
more quote information »

Recent News

Date Time Source Heading
3/30/202009:16GLOBELife Sciences Companies Investors Presentations Now..
3/27/202016:35EDGARProxy Statement - Notice of Shareholders Meeting..
3/26/202016:32EDGARCurrent Report Filing (8-k)
3/24/202008:30GLOBEVirtual Conference for Life Sciences Companies and Investors..
3/24/202007:30GLOBEMoleculin to Present at the Life Sciences Investor Forum
3/24/202003:05GLOBEWPD Pharmaceuticals Partners with CNS Pharmaceuticals on..
3/23/202016:10EDGARSecurities Registration Statement (simplified Form) (s-3/a)
3/20/202007:30PRNUSMoleculin Announces Patent Filing to Cover New Coronavirus..
3/19/202016:17EDGARCurrent Report Filing (8-k)
3/19/202016:14PRNUSMoleculin Biotech, Inc. Reports Financial Results for the..
3/19/202016:06EDGARAnnual Report (10-k)
3/19/202003:05GLOBEWPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF..
3/17/202007:31EDGARCurrent Report Filing (8-k)
3/17/202007:30PRNUSMoleculin Signs Agreement with UTMB to Test WP1122 on a..
3/10/202007:31EDGARCurrent Report Filing (8-k)
3/10/202007:30PRNUSMoleculin Announces Dr. Hongbo Zhai Joins Science Advisory..
3/04/202007:32EDGARCurrent Report Filing (8-k)
3/04/202007:30PRNUSMoleculin Issues Video Shareholder Letter
2/27/202003:05GLOBEWPD Pharmaceuticals’ Annamycin Received Positive Interim..
2/20/202007:33EDGARCurrent Report Filing (8-k)
2/20/202007:30PRNUSMoleculin Announces Positive Independent Report of No..
2/20/202003:05GLOBEWPD Pharmaceuticals' STAT3 Inhibitor Received FDA Approval..
2/18/202007:35GLOBEWPD Pharmaceuticals’ WP1220 Drug Demonstrates Median..
2/18/202007:31EDGARCurrent Report Filing (8-k)
2/18/202007:30PRNUSMoleculin Presents Clinical Trial Data Demonstrating a..
2/11/202016:45EDGARStatement of Ownership (sc 13g)
2/11/202014:17EDGARStatement of Ownership (sc 13g)
2/10/202015:17EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202013:36EDGARStatement of Ownership (sc 13g)
2/06/202017:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/06/202009:07EDGARCurrent Report Filing (8-k)
2/06/202009:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/06/202009:00PRNUSMoleculin Announces $6.0 Million Registered Direct Offering
2/05/202007:31EDGARCurrent Report Filing (8-k)
2/05/202007:30PRNUSMoleculin to Seek Accelerated FDA Approval and Plans for..
2/05/202003:05GLOBEWPD Pharmaceuticals’ Annamycin Drug Received FDA Approval of..
2/03/202007:33EDGARCurrent Report Filing (8-k)
2/03/202007:30PRNUSMoleculin Announces Successful Completion of US Phase 1 AML..
1/31/202016:05GLOBEWPD Pharmaceuticals Completed the Acquisition of Two..
1/21/202006:03EDGARWithdrawal of Registration Statement (rw)
1/17/202017:18EDGARSecurities Registration Statement (simplified Form) (s-3/a)
1/17/202016:37EDGARSecurities Registration Statement (simplified Form) (s-3)
1/13/202007:02EDGARCurrent Report Filing (8-k)
1/08/202006:01EDGARAmended Statement of Ownership (sc 13g/a)
12/23/201916:11EDGARSecurities Registration Statement (simplified Form) (s-3)
12/19/201916:07EDGARCurrent Report Filing (8-k)
12/19/201907:30PRNUSMoleculin Announces New Data Shows Reversal of Tumor..
12/04/201907:32EDGARCurrent Report Filing (8-k)
12/04/201907:30PRNUSMoleculin Announces Additional Positive Interim Results from..
11/19/201907:34EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
MBRX
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.